Latest Insider Transactions at Vickers Vantage Corp. I (VCKA)
This section provides a real-time view of insider transactions for Vickers Vantage Corp. I (VCKA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vickers Vantage Corp. I to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vickers Vantage Corp. I's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 31
2024
|
Henry Ji Executive Chairperson |
BUY
Open market or private purchase
|
Direct |
8,888
+2.7%
|
$0
$0.94 P/Share
|
Oct 29
2024
|
Jaisim Shah |
BUY
Open market or private purchase
|
Direct |
32,000
+22.64%
|
$0
$0.99 P/Share
|
Oct 18
2024
|
Dorman Followwill |
BUY
Open market or private purchase
|
Direct |
1,000
+30.3%
|
$0
$0.99 P/Share
|
Oct 18
2024
|
Jay Chun |
BUY
Open market or private purchase
|
Direct |
5,000
+4.26%
|
$0
$0.95 P/Share
|
Oct 17
2024
|
Yue Alexander Wu |
BUY
Open market or private purchase
|
Direct |
20,000
+44.44%
|
$0
$0.95 P/Share
|
Oct 17
2024
|
David Lemus |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$0
$0.9 P/Share
|
Oct 17
2024
|
Henry Ji Executive Chairperson |
BUY
Open market or private purchase
|
Indirect |
10,000
+14.27%
|
$0
$0.97 P/Share
|
Oct 16
2024
|
Jaisim Shah |
BUY
Open market or private purchase
|
Direct |
30,000
+27.95%
|
$0
$0.99 P/Share
|
Oct 16
2024
|
Stephen Hoi Ma Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
6,700
+22.68%
|
$0
$0.97 P/Share
|
Jun 26
2024
|
Dorman Followwill |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+43.48%
|
$1,000
$1.37 P/Share
|
Jun 20
2024
|
Yue Alexander Wu |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$5,000
$1.41 P/Share
|
Jun 20
2024
|
Stephen Hoi Ma Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+11.03%
|
$2,000
$1.41 P/Share
|
Jun 20
2024
|
Jay Chun |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.44%
|
$5,000
$1.41 P/Share
|
Jun 20
2024
|
Jaisim Shah |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+22.83%
|
$14,000
$1.73 P/Share
|
Jun 18
2024
|
Henry Ji Executive Chairperson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.89%
|
$6,000
$1.41 P/Share
|
Jun 14
2024
|
Jaisim Shah |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+50.0%
|
$33,333
$1.41 P/Share
|
May 17
2024
|
Jay Chun |
BUY
Open market or private purchase
|
Direct |
57,500
+35.94%
|
$0
$0.9 P/Share
|
May 17
2024
|
Henry Ji Executive Chairperson |
BUY
Open market or private purchase
|
Indirect |
50,000
+49.97%
|
$0
$0.88 P/Share
|
May 17
2024
|
Jaisim Shah |
BUY
Open market or private purchase
|
Indirect |
56,939
+26.75%
|
$0
$0.92 P/Share
|
May 17
2024
|
Stephen Hoi Ma Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,140
+50.0%
|
$0
$0.88 P/Share
|
May 16
2024
|
Jaisim Shah |
BUY
Open market or private purchase
|
Indirect |
83,061
+45.64%
|
$0
$0.84 P/Share
|
Sep 21
2023
|
Sorrento Therapeutics, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,068,585
-96.91%
|
-
|
Mar 17
2023
|
Henry Ji Executive Chairperson |
BUY
Other acquisition or disposition
|
Indirect |
2,730
+50.0%
|
$21,840
$8.6 P/Share
|
Jan 19
2023
|
Sorrento Therapeutics, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
73,740,795
-54.33%
|
-
|